December 22, 2011
Medical Device Daily
The Prometheus v. Mayo case was argued at the U.S. Supreme Court earlier in December, and while many of the justices’ questions seemed to reflect positions they were expected to hold, Chief Justice John Roberts asked questions that have prompted at least one patent attorney to speculate that Roberts might find the technology being litigated ineligible for patent protection, which would have a detrimental impact on the future of patents related to diagnostics and personalized medicine. Finnegan partner Denise DeFranco stated if the Court reversed the Federal Circuit, the outcome “could have major implications,” adding, “if they say this claim is invalid, no matter how narrowly they state that, there are a lot of claims like this one” that would be affected
Commentary
April 11, 2024
Media Mention
Women in Business Law Americas Awards 2024: Three Finnegan Attorneys Shortlisted
April 7, 2024
Press Release
Finnegan and BMW Group Successfully Demolish Non-Practicing Entity NorthStar’s Efforts
April 3, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.